Valion Bio, Inc. issued 250 Series B Preferred Shares at $1,000 per share and a warrant to purchase 156,026 shares of common stock at an exercise price of $0.616280 per share to 3i, LP for an aggregate purchase price of $250,000 on June 17, 2026. The company is a biotechnology company focused on developing medical devices or health technology solutions.
